Analgesic Solutions Presents Data On The Use Of MADDERS To Assess Potentially Abuse-Related Events In Clinical Trials At The Post author:Sam Post published:June 18, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like MilliporeSigma Opens China's First BioReliance End-to-End Biodevelopment Center In Shanghai September 21, 2017 Newron Pharma Shareholders Confirm Company Management March 27, 2017 Cutera Strengthens Leadership Team With Two Key Executive Appointments August 20, 2017
MilliporeSigma Opens China's First BioReliance End-to-End Biodevelopment Center In Shanghai September 21, 2017